[Can muscle relaxation prevent the development of pneumothorax in artificially ventilated newborn infants?].
A retrospective study was conducted on 37 ventilated newborn infants to find out whether muscle paralysis by pancuronium had prevented pneumothorax (pt) in those severely ill newborn infants. In the group of 21 newborns who developed pt, 17 (81%) had been paralyzed with pancuronium. In the group of 16 newborns without pt, 10 (61%) had received pancuronium (chi 2 = 1,568, ns). Thus, muscular paralysis had not prevented pt. Since the newborns in both groups were equally severely ill (mean compliance of the respiratory system 0.48 +/- 0.17 ml/cm H20 in the group with pt, 0.38 +/- 0.12 in the group without pt), we assume that pancuronium was unable to prevent pt in ventilated premature and full-term newborn infants. We therefore caution against the use of pancuronium as a paralytic drug known to have deleterious side effects.
Lischka
A
A
Universitäts-Kinderklinik, Wien.
Popow
C
C
Simbruner
G
G
D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D007384:Intermittent Positive-Pressure Breathing; D008170:Lung Compliance / Q000187:drug effects; D010197:Pancuronium / Q000627:therapeutic use*; D011030:Pneumothorax / Q000517:prevention & control*; D011175:Positive-Pressure Respiration; D011379:Prognosis; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy*
D010197:Pancuronium
Kann Muskelrelaxation das Entstehen eines Pneumothorax bei beatmeten Neugeborenen verhindern?